GIC Sub-Industry »Biotechnology« (200+)
Filter by Size, Price, EPS, Revenue, Debt, Returns and many other Dividend and Fundamental Data.
Results
200 matches| SYMBOL | INDUSTRY | MKT CAP | VRT | SIGNAL | RISK | RS | DIV. YIELD |
|---|---|---|---|---|---|---|---|
|
ABBV AbbVie |
Biotechnology
Medicines, Therapies, Injectables |
373B | 41 | -0.31 | 49 | 32 | 3.3% |
|
AMGN Amgen |
Biotechnology
Biologics, Treatments, Therapies |
190B | 67 | 0.25 | 60 | 68 | 3.1% |
|
GILD Gilead Sciences |
Biotechnology
Antivirals, Oncology, Rare Diseases |
169B | 65 | -0.06 | 86 | 78 | 2.7% |
|
NOV Novo Nordisk |
Biotechnology
Diabetes, Obesity, Rare Disease |
157B | 48 | -0.77 | 86 | 4 | 4.6% |
|
VRTX Vertex |
Biotechnology
Medicines, Therapies, Treatments |
110B | 59 | -0.38 | 91 | 31 | - |
|
REGN Regeneron |
Biotechnology
Eye Disease, Asthma, Cancer |
80.0B | 59 | -0.10 | 94 | 72 | 0.5% |
|
ARGX argenx |
Biotechnology
Biologics, Treatments, Autoimmune |
45.3B | 53 | 0.28 | 67 | 57 | - |
|
HLN Haleon |
Biotechnology
Oral Care, Vitamins, Pain Relief |
44.6B | 57 | -0.12 | 90 | 38 | 1.8% |
|
ALNY Alnylam |
Biotechnology
RNAi Therapeutics, Onpattro |
41.9B | 50 | -0.75 | 26 | 21 | - |
|
ONC BeiGene |
Biotechnology
Cancer Therapies, Immunotherapy |
34.1B | 43 | -0.56 | 41 | 54 | - |
|
INSM Insmed |
Biotechnology
Rare Disease Therapies, Lung |
33.0B | 41 | 0.29 | 24 | 85 | - |
|
BIIB Biogen |
Biotechnology
Neurology Drugs, Biosimilars, Rare |
27.5B | 56 | -0.01 | 90 | 71 | - |
|
NTRA Natera |
Biotechnology
Prenatal Screening, Cancer |
26.5B | 54 | 0.83 | 35 | 72 | - |
|
UTHR United Therapeutics |
Biotechnology
Treating Pulmonary Arterial |
25.8B | 63 | 0.02 | 78 | 89 | - |
|
BNTX BioNTech SE |
Biotechnology
Cancer, Vaccines, Immunotherapy |
22.3B | 34 | 0.05 | 84 | 23 | - |
|
MRNA Moderna |
Biotechnology
Vaccines, Oncology, Rare |
19.7B | 45 | -0.17 | 31 | 94 | - |
|
ROIV Roivant Sciences |
Biotechnology
Medicines, Therapies, Antibodies |
19.6B | 49 | 0.88 | 80 | 97 | - |
|
INCY Incyte |
Biotechnology
Cancer Therapies, Dermatology |
18.7B | 70 | 0.62 | 83 | 74 | - |
|
RVMD Revolution |
Biotechnology
Cancer Therapies, Drug |
18.3B | 54 | 0.55 | 80 | 98 | - |
|
GMAB Genmab AS |
Biotechnology
Antibody Therapies, Cancer Drugs |
16.5B | 58 | 0.42 | 64 | 58 | - |
|
BBIO BridgeBio Pharma |
Biotechnology
Genetic Medicines, Small |
14.4B | 41 | 0.08 | 30 | 88 | - |
|
ASND Ascendis Pharma AS |
Biotechnology
Endocrinology, Therapies, Rare |
14.0B | 47 | -0.50 | 32 | 78 | - |
|
NBIX Neurocrine |
Biotechnology
Neurological Drugs, Endocrine |
13.2B | 52 | -0.06 | 87 | 38 | - |
|
SMMT Summit Therapeutics |
Biotechnology
Oncology Drug, Immunotherapy |
13.2B | 18 | -0.12 | 75 | 33 | - |
|
ERF Eurofins |
Biotechnology
Testing, Laboratory, Analysis |
12.8B | 67 | 0.25 | 84 | 69 | 1.1% |
|
BIM Biomerieux |
Biotechnology
Diagnostic Tests, Culture Media |
12.2B | 54 | -0.02 | 96 | 15 | 0.7% |
|
MDGL Madrigal |
Biotechnology
Liver Drug, MASH Treatment |
12.0B | 35 | 0.12 | 21 | 83 | - |
|
IONS Ionis |
Biotechnology
RNA Medicines, Genetic Diseases |
11.9B | 48 | 0.22 | 59 | 89 | - |
|
EXEL Exelixis |
Biotechnology
Cancer Drugs, Targeted Therapies |
11.8B | 54 | 0.21 | 89 | 52 | - |
|
BMRN Biomarin |
Biotechnology
Rare Disease Therapies, Enzyme |
10.4B | 45 | -0.49 | 91 | 25 | - |
|
ABVX Abivax |
Biotechnology
Obefazimod, UlcerativeColitis |
8.18B | 44 | -0.36 | 41 | 99 | - |
|
CYTK Cytokinetics |
Biotechnology
Muscle Activators, Muscle |
8.12B | 43 | 0.15 | 30 | 87 | - |
|
ABVX Abivax American |
Biotechnology
Obefazimod |
8.12B | 33 | -0.21 | 36 | 99 | - |
|
QIA QIAGEN |
Biotechnology
Diagnostics, Research Tools, Lab |
8.11B | 40 | -0.42 | 89 | 23 | 5.4% |
|
ARWR Arrowhead |
Biotechnology
RNAi, Hepatic, Metabolic |
8.09B | 65 | -0.59 | 25 | 99 | - |
|
PRAX Praxis Precision |
Biotechnology
Ulixacaltamide, Vormatrigine |
8.08B | 44 | -0.23 | 67 | 99 | - |
|
NUVL Nuvalent |
Biotechnology
Cancer Therapies, Drug Candidates |
8.05B | 47 | 0.28 | 72 | 78 | - |
|
PCVX Vaxcyte |
Biotechnology
Vaccines, Pneumococcal, Bacterial |
7.72B | 33 | 0.28 | 77 | 91 | - |
|
HALO Halozyme |
Biotechnology
Enzymes, Drug Delivery, Biologics |
7.30B | 55 | 0.08 | 78 | 34 | - |
|
KRYS Krystal Biotech |
Biotechnology
Genetic Medicines, Skin |
7.17B | 58 | 0.90 | 87 | 86 | - |
|
ACLX Arcellx |
Biotechnology
Cancer Therapies, Immunotherapies |
6.70B | 43 | 0.54 | 72 | 95 | - |
|
KYMR Kymera Therapeutics |
Biotechnology
Drug Discovery, Protein |
6.38B | 53 | 0.56 | 80 | 96 | - |
|
PTGX Protagonist |
Biotechnology
Oral Peptides, Injectable |
6.32B | 48 | 0.55 | 36 | 94 | - |
|
COGT Cogent Biosciences |
Biotechnology
Cancer Drugs, Genetic Therapies |
6.25B | 50 | 0.10 | 69 | 99 | - |
|
APGE Apogee |
Biotechnology
Biologics, Antibodies, Treatments |
5.87B | 43 | 0.41 | 80 | 95 | - |
|
BLTE Belite Bio |
Biotechnology
Eye Disease, Liver Disease |
5.87B | 40 | 0.21 | 80 | 98 | - |
|
CGON CG Oncology |
Biotechnology
Cancer Therapies, Bladder Cancer |
5.63B | 39 | 0.95 | 34 | 98 | - |
|
MIRM Mirum |
Biotechnology
Rare Disease Treatments, Liver |
5.57B | 56 | 0.28 | 36 | 92 | - |
|
CELC Celcuity |
Biotechnology
Drug Candidates, Diagnostics |
5.52B | 59 | 0.49 | 80 | 99 | - |
|
PTCT PTC Therapeutics |
Biotechnology
Rare Disease Drugs, Gene Therapy |
5.43B | 61 | 0.08 | 58 | 66 | - |
|
XENE Xenon |
Biotechnology
Neurological Therapeutics |
5.30B | 41 | 0.42 | 26 | 91 | - |
|
RYTM Rhythm |
Biotechnology
Rare Diseases, Obesity |
5.18B | 37 | -0.62 | 40 | 61 | - |
|
TGTX TG Therapeutics |
Biotechnology
Antibodies, Cancer Treatments |
5.07B | 24 | 0.02 | 26 | 34 | - |
|
IMVT Immunovant |
Biotechnology
Antibodies, Treatments, Diseases |
5.06B | 37 | -0.37 | 34 | 80 | - |
|
ALKS Alkermes |
Biotechnology
Schizophrenia, Bipolar, Alcohol |
4.90B | 54 | 0.34 | 73 | 72 | - |
|
SRRK Scholar Rock |
Biotechnology
Antibody, Inhibitor, Myostatin |
4.89B | 41 | 0.21 | 69 | 85 | - |
|
DIA DiaSorin S.p.A. |
Biotechnology
Diagnostic Kits, Molecular |
4.77B | 43 | -0.03 | 77 | 13 | 1.3% |
|
ERAS Erasca |
Biotechnology
Cancer Therapies, Drug |
4.71B | 49 | 1.33 | 70 | 99 | - |
|
CRSP Crispr Therapeutics |
Biotechnology
Gene Editing, Cell Therapy, Drug |
4.39B | 36 | -0.35 | 79 | 33 | - |
|
DNTH Dianthus |
Biotechnology
Antibodies, Therapeutics |
4.37B | 38 | 0.51 | 41 | 99 | - |
|
CNTA Centessa |
Biotechnology
Medicines, Treatments |
4.19B | 39 | 0.11 | 21 | 98 | - |
|
SYRE Spyre Therapeutics |
Biotechnology
Antibodies, Inflammatory Disease |
3.96B | 49 | 0.27 | 67 | 99 | - |
|
LGND Ligand |
Biotechnology
Antiviral, Oncology, Nephrology |
3.90B | 56 | -0.20 | 81 | 86 | - |
|
CRNX Crinetics |
Biotechnology
Paltusotine, Atumelnant, CRN09682 |
3.80B | 24 | 0.11 | 41 | 33 | - |
|
ACAD ACADIA |
Biotechnology
Antipsychotic, Trofinetide |
3.80B | 33 | -0.05 | 28 | 43 | - |
|
VKTX Viking Therapeutics |
Biotechnology
Metabolic Therapies, Endocrine |
3.76B | 41 | -0.28 | 80 | 71 | - |
|
INDV Indivior Ordinary |
Biotechnology
Extended-Release Injection |
3.62B | 61 | 0.68 | 46 | 94 | - |
|
KNSA Kiniksa |
Biotechnology
Cardiovascular Therapies, Skin |
3.50B | 56 | 0.86 | 54 | 91 | - |
|
NAMS NewAmsterdam |
Biotechnology
Cardiometabolic Therapies |
3.45B | 33 | -0.06 | 23 | 83 | - |
|
EWTX Edgewise |
Biotechnology
Muscle Therapies, Cardiac |
3.38B | 50 | 0.44 | 80 | 97 | - |
|
GPCR Structure |
Biotechnology
Obesity Drugs, Fibrosis Drugs |
3.11B | 49 | 0.31 | 80 | 97 | - |
|
LEGN Legend Biotech |
Biotechnology
Cell Therapies, Oncology, Cancer |
3.11B | 17 | -0.62 | 41 | 7 | - |
|
DYN Dyne Therapeutics |
Biotechnology
Muscle Disease, Therapeutics |
2.99B | 53 | 0.11 | 73 | 91 | - |
|
TNGX Tango Therapeutics |
Biotechnology
Oncology Drugs, Cancer Treatments |
2.99B | 53 | 0.61 | 66 | 99 | - |
|
TWST Twist Bioscience |
Biotechnology
Synthetic DNA, Gene Synthesis |
2.91B | 36 | 0.49 | 43 | 90 | - |
|
CPRX Catalyst |
Biotechnology
Rare Disease Treatments, Seizure |
2.88B | 59 | 0.51 | 70 | 61 | - |
|
DNLI Denali Therapeutics |
Biotechnology
Neuro Drugs, Enzyme Therapy |
2.87B | 45 | 0.23 | 76 | 86 | - |
|
ALMS Alumis |
Biotechnology
TYK2 Inhibitor, Autoimmune Drug |
2.80B | 41 | -0.12 | 23 | 99 | - |
|
VERA Vera Therapeutics |
Biotechnology
Biologics, Antibodies, Therapies |
2.77B | 51 | -0.17 | 80 | 83 | - |
|
IDYA Ideaya Biosciences |
Biotechnology
Oncology Therapeutics, Drug |
2.67B | 35 | -0.32 | 35 | 84 | - |
|
ARQT Arcutis |
Biotechnology
Skin Treatments, Topical Creams |
2.63B | 38 | -0.31 | 24 | 73 | - |
|
RCUS Arcus Biosciences |
Biotechnology
Antibody, Inhibitor, Cancer |
2.54B | 51 | 0.60 | 59 | 97 | - |
|
TVTX Travere |
Biotechnology
Sparsentan, Tiopronin, Filspari |
2.51B | 48 | -0.81 | 25 | 83 | - |
|
ORKA Oruka Therapeutics |
Biotechnology
Antibodies, Inflammation |
2.43B | 47 | 0.80 | 77 | 99 | - |
|
BCRX BioCryst |
Biotechnology
Influenza Treatments, Rare Disease |
2.39B | 66 | -0.24 | 30 | 72 | - |
|
VCYT Veracyte |
Biotechnology
Cancer Tests, Genomic Analysis |
2.38B | 33 | -0.24 | 43 | 26 | - |
|
IRON Disc Medicine |
Biotechnology
Blood Disorders, Drug Development |
2.29B | 39 | -0.76 | 73 | 50 | - |
|
BEAM Beam Therapeutics |
Biotechnology
Gene Editing, Therapeutics, RNA |
2.26B | 34 | -0.16 | 75 | 57 | - |
|
DAWN Day One |
Biotechnology
Cancer Drugs, Clinical Trials |
2.21B | 41 | 0.50 | 29 | 99 | - |
|
IMNM Immunome |
Biotechnology
Cancer Therapies, Drug Candidates |
2.18B | 48 | -0.27 | 74 | 97 | - |
|
SRPT Sarepta |
Biotechnology
Exon-Skipping Injection, Gene |
2.15B | 21 | -0.06 | 29 | 31 | - |
|
SNDX Syndax |
Biotechnology
Cancer Therapies, Leukemia |
2.07B | 41 | 0.93 | 26 | 96 | - |
|
ZLAB Zai Lab |
Biotechnology
Cancer Drugs, Autoimmune Drugs |
2.03B | 17 | -1.30 | 30 | 15 | - |
|
AGIO Agios Pharm |
Biotechnology
Medicines, Anemias, Thalassemia |
1.98B | 32 | -0.33 | 29 | 68 | - |
|
CLDX Celldex |
Biotechnology
Antibodies, Therapeutics |
1.96B | 30 | -0.12 | 31 | 85 | - |
|
MLYS Mineralys |
Biotechnology
Medicines, Treatments, Aldosterone |
1.95B | 44 | 0.15 | 62 | 75 | - |
|
STOK Stoke Therapeutics |
Biotechnology
Genetic Therapies, Antisense |
1.94B | 52 | -0.28 | 31 | 99 | - |
|
MESO Mesoblast |
Biotechnology
Cell Therapy, Inflammation, Heart |
1.94B | 16 | -1.35 | 36 | 44 | - |
|
GLPG Galapagos |
Biotechnology
Oncology Drugs, Immunology Drugs |
1.91B | 47 | -0.41 | 66 | 30 | - |
|
AUPH Aurinia |
Biotechnology
Autoimmune Therapies, Lupus |
1.90B | 63 | 0.94 | 30 | 90 | - |
|
RARE Ultragenyx |
Biotechnology
Biologics, Gene Therapy, Enzyme |
1.87B | 28 | -0.12 | 41 | 11 | - |
|
TYRA Tyra Biosciences |
Biotechnology
Biologics, Therapies, Oncology |
1.86B | 56 | 1.10 | 80 | 99 | - |
|
ZYME Zymeworks Common |
Biotechnology
Antibody Therapeutics, Cancer |
1.86B | 34 | -0.52 | 36 | 91 | - |
|
PHVS Pharvaris BV |
Biotechnology
Rare Disease Therapies, Angioedema |
1.84B | 52 | 0.14 | 78 | 87 | - |
|
SLNO Soleno Therapeutics |
Biotechnology
Rare diseases, Tablets |
1.80B | 35 | -0.64 | 61 | 5 | - |
|
RLAY Relay Therapeutics |
Biotechnology
Oncology Drugs, Genetic Drugs |
1.78B | 61 | 0.94 | 80 | 99 | - |
|
CAPR Capricor |
Biotechnology
Cell Therapies, Exosome Therapies |
1.66B | 52 | 0.55 | 65 | 99 | - |
|
ANAB AnaptysBio |
Biotechnology
Antibodies, Therapeutics |
1.65B | 68 | -0.16 | 36 | 98 | - |
|
SION Sionna |
Biotechnology
Drug Development, Clinical Trials |
1.65B | 49 | -0.03 | 80 | 96 | - |
|
PVLA Palvella |
Biotechnology
Genetic Skin, Rare Diseases |
1.57B | 45 | -0.26 | 73 | 99 | - |
|
RXRX Recursion |
Biotechnology
Drug Discovery, Clinical Trials |
1.55B | 26 | -0.53 | 41 | 4 | - |
|
NRIX Nurix Therapeutics |
Biotechnology
Cancer Drugs, Autoimmune Drugs |
1.52B | 47 | -0.56 | 80 | 76 | - |
|
NANO Nanobiotix S.A |
Biotechnology
Cancer Therapy, Nanoparticles |
1.51B | 31 | -0.76 | 25 | 99 | - |
|
VCEL Vericel Ord |
Biotechnology
Cellular Therapies, Skin |
1.49B | 41 | 0.00 | 77 | 24 | - |
|
IMCR Immunocore Holdings |
Biotechnology
Cancer Drugs, Viral Cures |
1.49B | 18 | -0.64 | 74 | 26 | - |
|
NUVB Nuvation Bio |
Biotechnology
Cancer Drugs, Lung Cancer, Solid |
1.49B | 44 | -0.40 | 31 | 86 | - |
|
MEDCL Medincell |
Biotechnology
Injectables, Pharmaceuticals |
1.47B | 49 | -0.39 | 34 | 71 | - |
|
NTLA Intellia |
Biotechnology
In Vivo, Ex Vivo, CRISPR, CAR-T |
1.46B | 47 | -0.39 | 34 | 83 | - |
|
OCS Oculis Holding |
Biotechnology
Eye Treatments, Drug Candidates |
1.42B | 28 | -0.28 | 31 | 88 | - |
|
MBX MBX Biosciences |
Biotechnology
Peptide Therapies, Endocrine |
1.42B | 48 | 0.09 | 80 | 99 | - |
|
NVAX Novavax |
Biotechnology
Vaccines, Infectious Diseases |
1.38B | 44 | -0.97 | 27 | 58 | - |
|
PGEN Precigen |
Biotechnology
Gene Therapies, Cell Therapies |
1.36B | 35 | -0.31 | 29 | 94 | - |
|
ORIC Oric |
Biotechnology
Cancer Therapies, Drug |
1.35B | 39 | -0.19 | 69 | 56 | - |
|
ARDX Ardelyx |
Biotechnology
IBS Therapy, Phosphate Reducer |
1.34B | 35 | -0.60 | 30 | 68 | - |
|
VIR Vir Biotechnology |
Biotechnology
Antibodies, Therapies, Vaccines |
1.34B | 43 | 0.08 | 30 | 92 | - |
|
BCAX Bicara |
Biotechnology
Cancer Drugs, Antibodies, Therapies |
1.29B | 46 | 0.85 | 80 | 93 | - |
|
BHVN Biohaven |
Biotechnology
Neurological Therapies, Oncology |
1.27B | 28 | -0.68 | 80 | 8 | - |
|
IMTX Immatics |
Biotechnology
Cancer Therapies, Cell Therapy |
1.25B | 41 | 0.25 | 38 | 91 | - |
|
GLUE Monte Rosa |
Biotechnology
Drug Discovery, Cancer Treatments |
1.24B | 40 | 0.05 | 36 | 99 | - |
|
MLTX MoonLake |
Biotechnology
Inflammatory Therapies, Skin |
1.24B | 31 | -0.20 | 65 | 76 | - |
|
ATAI ATAI Life Sciences |
Biotechnology
Mental Health, Psychedelics |
1.22B | 38 | -0.15 | 26 | 84 | - |
|
IVA Inventiva S.A |
Biotechnology
Lanifibranor, Odiparcil, TGF-ß |
1.20B | 38 | -0.04 | 26 | 86 | - |
|
PHARM Pharming |
Biotechnology
Rare Disease Therapies, Protein |
1.18B | 57 | -0.59 | 48 | 84 | - |
|
CRVS Corvus |
Biotechnology
Cancer Treatments, Immune |
1.18B | 45 | 0.43 | 65 | 99 | - |
|
OLMA Olema |
Biotechnology
Cancer Therapies, Drug |
1.17B | 52 | -0.18 | 73 | 98 | - |
|
TSHA Taysha Gene |
Biotechnology
Gene Therapies, Nervous System |
1.17B | 58 | 0.17 | 80 | 92 | - |
|
DBVT DBV Technologies |
Biotechnology
Allergy Treatments, Patches |
1.11B | 38 | -0.11 | 31 | 96 | - |
|
SVRA Savara |
Biotechnology
Rare Diseases, Respiratory |
1.05B | 51 | -0.06 | 62 | 94 | - |
|
ABCL Abcellera Biologics |
Biotechnology
Antibody Drugs, Drug Discovery |
991M | 49 | -0.03 | 76 | 48 | - |
|
INBX Inhibrx |
Biotechnology
Biologics, Therapeutics, Cancer |
982M | 41 | -0.55 | 32 | 99 | - |
|
ALVO Alvotech |
Biotechnology
Biologics, Therapeutics |
969M | 18 | -0.85 | 36 | 2 | - |
|
CMPX Compass |
Biotechnology
Tovecimig, CTX-471, CTX-8371 |
953M | 50 | 0.49 | 65 | 96 | - |
|
AVBP ArriVent |
Biotechnology
Firmonertinib, ARR-217, ARR-002 |
929M | 37 | -0.06 | 65 | 80 | - |
|
GERN Geron |
Biotechnology
Cancer Drugs, Therapeutics |
897M | 28 | -0.22 | 30 | 74 | - |
|
CDNA CareDx |
Biotechnology
Transplant Testing, Gene |
893M | 37 | 0.17 | 38 | 39 | - |
|
OPK Opko Health |
Biotechnology
Diagnostics, Pharmaceuticals |
860M | 20 | -0.32 | 33 | 14 | - |
|
VOR Vor Biopharma |
Biotechnology
Cell Therapies, Gene Therapies |
849M | 49 | -0.86 | 75 | 66 | - |
|
MPLT MapLight |
Biotechnology
CNS Treatments, Drug Candidates |
842M | 44 | 0.08 | 63 | 75 | - |
|
ABUS Arbutus Biopharma |
Biotechnology
Hepatitis B, RNAi, Immune Response |
839M | 26 | -0.45 | 26 | 64 | - |
|
XNCR Xencor |
Biotechnology
Antibodies, Biologics |
838M | 28 | 0.00 | 38 | 67 | - |
|
KALV Kalvista |
Biotechnology
Drug Therapies, Small Molecules |
832M | 47 | 0.51 | 24 | 92 | - |
|
URGN UroGen Pharma |
Biotechnology
Cancer Drugs, Hydrogel Technology |
828M | 41 | -0.36 | 31 | 73 | - |
|
GHRS GH Research |
Biotechnology
Depression Treatments, Drug |
816M | 41 | -0.83 | 66 | 67 | - |
|
JANX Janux Therapeutics |
Biotechnology
Cancer Drugs, Immunotherapies |
802M | 19 | -0.26 | 26 | 13 | - |
|
SPRY ARS |
Biotechnology
Neffy, Nasal, Epinephrine |
801M | 20 | -0.61 | 36 | 6 | - |
|
CGEM Cullinan Oncology |
Biotechnology
Cancer Drugs, Autoimmune Drugs |
778M | 41 | 0.02 | 65 | 96 | - |
|
BTX BlackRock |
Biotechnology
Technology, Private Equity |
770M | 23 | 0.10 | 59 | 54 | 12.0% |
|
ANNX Annexon |
Biotechnology
Biologics, Small Molecules |
745M | 58 | -0.35 | 80 | 96 | - |
|
SANA Sana Biotechnology |
Biotechnology
Cell Therapy, Diabetes Treatment |
715M | 42 | 0.10 | 65 | 58 | - |
|
MGTX MeiraGTx Holdings |
Biotechnology
Gene Therapies, Ocular Treatments |
705M | 37 | -0.02 | 26 | 79 | - |
|
ESPR Esperion |
Biotechnology
Cholesterol Medication |
704M | 36 | -1.12 | 26 | 82 | - |
|
MNKD MannKind |
Biotechnology
Inhaled Insulin, Wearable Insulin |
702M | 34 | -0.68 | 26 | 1 | - |
|
CSTL Castle Biosciences |
Biotechnology
Melanoma, Squamous-Cell, Uveal |
700M | 46 | 0.18 | 57 | 31 | - |
|
LXRX Lexicon |
Biotechnology
Drugs, Treatments, Research |
699M | 42 | -0.37 | 31 | 96 | - |
|
DRUG Bright Minds |
Biotechnology
Drug Development, Serotonin |
686M | 44 | -0.10 | 80 | 91 | - |
|
KURA Kura Oncology |
Biotechnology
Cancer Drugs, Leukemia Treatment |
684M | 31 | 0.10 | 34 | 59 | - |
|
DSGN Design Therapeutics |
Biotechnology
Small Molecules, Genetic Diseases |
656M | 56 | 0.52 | 80 | 98 | - |
|
PRME Prime Medicine |
Biotechnology
Gene Editing, Genetic Therapies |
610M | 41 | -1.06 | 69 | 55 | - |
|
REPL Replimune |
Biotechnology
Cancer Therapies, Immunotherapies |
595M | 28 | 0.29 | 29 | 64 | - |
|
DRTS Alpha Tau Medical |
Biotechnology
Cancer Therapy, Radiation Therapy |
576M | 46 | -0.22 | 80 | 97 | - |
|
IRWD Ironwood |
Biotechnology
GI Therapies, Rare Disease, Pain |
572M | 65 | -0.63 | 31 | 98 | - |
|
MDXG MiMedx |
Biotechnology
Placental Allografts, Amniotic |
566M | 45 | -0.66 | 85 | 3 | - |
|
ZURA Zura Bio Ordinary |
Biotechnology
Antibodies, Biologics, Therapeutics |
563M | 45 | -0.80 | 80 | 99 | - |
|
TECX Tectonic |
Biotechnology
Biologics, Proteins, Antibodies |
551M | 48 | -0.80 | 80 | 94 | - |
|
ZVRA Zevra Therapeutics |
Biotechnology
KP1077, Celiprolol, AZSTARYS |
538M | 49 | -0.48 | 31 | 61 | - |
|
PRTA Prothena |
Biotechnology
Antibody, Vaccine |
498M | 30 | -0.35 | 61 | 62 | - |
|
DBV DBV Technologies |
Biotechnology
Peanut Patch, Milk Patch |
488M | 42 | -0.48 | 36 | 96 | - |
|
CLYM Climb Bio |
Biotechnology
Antibodies, Therapies, Diseases |
479M | 45 | -0.99 | 65 | 99 | - |
|
RIGL Rigel |
Biotechnology
Cancer Drugs, Blood Disorders |
477M | 53 | -0.02 | 35 | 54 | - |
|
FDMT 4D Molecular |
Biotechnology
Gene Therapy, Drug Development |
475M | 58 | 0.19 | 66 | 96 | - |
|
VSTM Verastem |
Biotechnology
Cancer Drugs, Small Molecules |
466M | 19 | -0.75 | 31 | 18 | - |
|
KYTX Kyverna |
Biotechnology
Cell Therapy, Autoimmune Disease |
458M | 50 | -0.47 | 75 | 98 | - |
|
TRDA Entrada |
Biotechnology
Drug Delivery, RNA Therapeutics |
457M | 48 | -0.12 | 79 | 94 | - |
|
LRMR Larimar |
Biotechnology
Rare Disease Treatments, Peptide |
448M | 55 | -0.32 | 72 | 91 | - |
|
STTK Shattuck Labs |
Biotechnology
Antibodies, Biologics, Oncology |
427M | 54 | 0.16 | 65 | 99 | - |
|
ABSI Absci |
Biotechnology
Drug Discovery, AI, Antibodies |
425M | 32 | -1.06 | 65 | 33 | - |
|
EPRX Eupraxia |
Biotechnology
Drug Delivery, Pain Relief |
413M | 48 | -0.44 | 80 | 84 | - |
|
EBS Emergent |
Biotechnology
Vaccines, Treatments |
411M | 46 | -1.13 | 85 | 34 | - |
|
VNDA Vanda |
Biotechnology
Medications, Therapies |
408M | 45 | -0.23 | 36 | 76 | - |
|
RGNX Regenxbio |
Biotechnology
Gene Therapy, Drug Candidates |
401M | 21 | -1.12 | 40 | 18 | - |
|
MYGN Myriad Genetics |
Biotechnology
Cancer Tests, Health Screens |
400M | 16 | -0.61 | 33 | 8 | - |
|
AURA Aura Biosciences |
Biotechnology
Cancer Therapies, Oncology Drugs |
398M | 39 | -0.58 | 65 | 67 | - |
|
LXEO Lexeo |
Biotechnology
Gene Therapy, Cardiovascular |
385M | 40 | -1.01 | 80 | 54 | - |
|
ALT Altimmune |
Biotechnology
Obesity Treatments, Liver Disease |
375M | 27 | -0.10 | 41 | 15 | - |
|
AKBA Akebia Ther |
Biotechnology
Kidney Disease, Anemia, Iron |
372M | 38 | -1.16 | 33 | 6 | - |
|
LCTX Lineage Cell |
Biotechnology
OpRegen, OPC1, VAC2, ANP1, PNC1 |
371M | 46 | -0.70 | 30 | 93 | - |
|
XFOR X4 Pharmaceuticals |
Biotechnology
Rare Diseases, Immune System |
367M | 27 | -1.16 | 26 | 79 | - |
|
DMAC DiaMedica |
Biotechnology
Biologics, Therapies, Treatments |
364M | 45 | -0.69 | 74 | 76 | - |
|
XOMA XOMA |
Biotechnology
Biotech, Royalties, Licensing |
359M | 46 | 0.03 | 27 | 78 | - |
|
MNPR Monopar |
Biotechnology
Cancer Drugs, Imaging Agents |
357M | 45 | -0.93 | 80 | 52 | - |
Basic Filter
Fundamental
Technical